LEF1 is also a facilitator of EMT, a feature of cancer cell migration and invasion, as well as cancer cell proliferation and viability.17 Undoubtedly, the crucial position of LEF1 in cancer progression makes this protein an ideal biomarker for predicting patient prognosis, which shows the value of its clinical application. This evidence concerns the gene LEF1 and cancer.